Notable Aurinia Pharmaceuticals Insider Trades $2.92 Million In Company Stock
Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals (NASDAQ:AUPH), made a large buy and sell of company shares on September 14, according to a new SEC filing.
